(Q34378095)

1 August 2017

title

Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo (English)

1 reference

1 August 2017

Wei Li

1

1 reference

1 August 2017

Hong-Ru Jiang

2

1 reference

1 August 2017

Xiao-Li Xu

3

1 reference

1 August 2017

Jie Wang

4

1 reference

1 August 2017

Jun Zhang

5

1 reference

1 August 2017

Mei-Lin Liu

6

1 reference

1 August 2017

Ling-Yun Zhai

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

19 October 2010

1 reference

International Journal of Molecular Sciences

1 August 2017

published in

1 reference

1 August 2017

volume

11

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

3999-4013

1 reference

Creative Commons Attribution 4.0 International

1 August 2017

copyright license

start time

19 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

The anti-proliferative potency of celecoxib is not a class effect of coxibs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cyclin D1 in breast cancer pathogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Genetic and epigenetic alterations as hallmarks of the intricate road to cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cyclooxygenase-2: a novel target for cancer chemotherapy?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Apoptosis and its clinical impact

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

The role of cyclooxygenases in inflammation, cancer, and development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers

6 July 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS11103999

Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996781

Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer

27 October 2018

1 reference

12 December 2020

Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas: comparison of mitotic and pyknotic (apoptotic) indices

1 reference

12 December 2020

Vascular permeability factor gene expression in normal and neoplastic human ovaries

1 reference

12 December 2020

Overexpression of cyclin D1 in epithelial ovarian cancers

1 reference

12 December 2020

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice

1 reference

12 December 2020

Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer

1 reference

12 December 2020

Celecoxib inhibits meningioma tumor growth in a mouse xenograft model

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS11103999

1 reference

1 August 2017

1 reference

1 August 2017

1 reference